AKER Up On Aero-Med Deal, Allergy Under The Weather, RGLS Falls On Clinical Hold

Shares of Regulus Therapeutics Inc. (RGLS) plunged over 53% in extended trading on Monday, following clinical hold on the company's drug candidate RG-101 for the treatment of chronic hepatitis C virus.

from RTT - Biotech http://ift.tt/292gdSf
via IFTTT